Table 1.
Patient characteristics–primary tumours
| Category | Subcategory | HCC (n = 422) | ICC (n = 120) | All (n = 542) |
|---|---|---|---|---|
| ECOG status | 0–fully active | 252 (59.7%) | 65 (54.2%) | 317 (58.5%) |
| 1–restricted | 136 (32.2%) | 41 (34.2%) | 177 (32.7%) | |
| 2 or higher | 34 (8.1%) | 11 (9.2%) | 45 (8.3%) | |
| Missingb | – | 3 (2.5%) | 3 (0.6%) | |
| Extra-hepatic disease | No | 382 (90.5%) | 84 (70.0%) | 466 (86.0%) |
| Yes | 40 (9.5%) | 36 (30.0%) | 76 (14.0%) | |
| Ascites | No | 357 (84.6%) | 107 (89.2%) | 464 (85.7%) |
| Yes | 65 (15.4%) | 13 (10.8%) | 78 (14.3%) | |
| Cirrhosis | No | 122 (28.9%) | 105 (87.5%) | 227 (41.9%) |
| Yes | 300 (71.1%) | 15 (12.5%) | 315 (58.1%) | |
| Location of liver tumours | Bilobar | 159 (37.7%) | 71 (59.2%) | 230 (42.4%) |
| Left only | 51 (12.1%) | 16 (13.3%) | 67 (12.4%) | |
| Right only | 212 (50.2%) | 33 (27.5%) | 245 (45.2%) | |
| Number of liver tumours | 1 | 110 (26.1%) | 32 (26.7%) | 142 (26.2%) |
| 2–5 | 154 (36.5%) | 35 (29.2%) | 189 (34.9%) | |
| 6–9 | 23 (5.5%) | 10 (8.3%) | 33 (6.1%) | |
| 10 or more | 55 (13.0%) | 10 (8.3%) | 65 (12.0%) | |
| Uncountable | 80 (19.0%) | 33 (27.5%) | 113 (20.8%) | |
| Portal vein | Patent | 282 (66.8%) | 95 (79.2%) | 377 (69.6%) |
| Segmental thrombosis | 82 (19.4%) | 14 (11.7%) | 96 (17.8%) | |
| Lobar thrombosis | 38 (9.0%) | 7 (5.8%) | 45 (8.3%) | |
| Main thrombosis | 20 (4.7%) | 4 (3.3%) | 24 (4.4%) | |
| Total tumour to liver percentage | Median | 9.2% | 12.8% | 10.0% |
| Q1, Q3 | 3.4%, 20.2% | 7.9%, 21.5% | 4.4%, 20.4% | |
| Missing | 67 (15.9%) | 23 (19.2%) | 90 (16.7%) |